Standardized Nutritional Management of Pediatric Patients With Solid Tumors
- Conditions
- Tumor, SolidChildrenNutritional Intervention
- Registration Number
- NCT06730204
- Lead Sponsor
- Children's Hospital of Fudan University
- Brief Summary
The purpose of this study is to establish a standardized nutrition intervention procedure for children with solid tumors, and to explore the effectiveness and clinical applicability of standardized nutrition management and short peptide-based enteral nutrition intervention for improving the nutritional status of children with malignant solid tumors.
After admission, patients in the intervention group will receive standardized nutrition management provided by a nutrition support team composed of dietitians, nutritionists, clinicians, and nursing teams. Basic information, including diet, enteral and parenteral nutrition, nutritional status and clinical data, will be collected during the study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 400
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Weight for age Z score 1, 2, 3, 6, 12, 18, and 24 months after enrollment Weight for age Z score = (Actual weight - reference population median) / reference population standard deviation
height/length for age Z score 1, 2, 3, 6, 12, 18, and 24 months after enrollment Height/length for age Z score = (Actual height/length - reference population median) / reference population standard deviation
BMI for age Z score 1, 2, 3, 6, 12, 18, and 24 months after enrollment BMI for age Z score = (Actual BMI - reference population median) / reference population standard deviation
- Secondary Outcome Measures
Name Time Method dietary intake 1, 2, 3, 6, 12, 18, and 24 months after enrollment Unit: kcal/d A 24-hour dietary survey record will be conducted on the children to evaluate the quantity, type and energy of the food consumed.
serum albumin 1, 2, 3, 6, 12, 18, and 24 months after enrollment Unit: g/L This indicator is measured by the biochemical assembly line Remisol in the hospital laboratory department.
serum prealbumin 1, 2, 3, 6, 12, 18, and 24 months after enrollment Unit: mg/L This indicator is measured by the biochemical assembly line Remisol in the hospital laboratory department.
hemoglobin 1, 2, 3, 6, 12, 18, and 24 months after enrollment Unit: g/L This indicator is measured by the hemocytometer XS800I in the hospital laboratory department.
electrolytes 1, 2, 3, 6, 12, 18, and 24 months after enrollment Unit: mmol/L This indicator is measured by the biochemical assembly line Remisol in the hospital laboratory department.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Children's Hospital of Fudan University
🇨🇳Shanghai, Shanghai, China